Pfizer completes sale of animal health biz for Rs 471.60 cr
- Elections 2014 LIVE: Rahul Gandhi addresses a rally in Aurangabad; BJP in UP downplays dissent within the party over ticket distribution
- RBI: Growth rate to stay under 6 per cent
- Narendra Modi has deep character flaws... wouldâve fought in Varanasi if I knew Hindi: PC
- SC dismisses Centre's plea to review decision on Rajiv Gandhi killers
- US visa ban on Narendra Modi to be lifted if he becomes PM: Report
Drug major Pfizer Ltd today said it has completed the sale of its subsidiary PAPPL to Pfizer Animal Health India Ltd (PAHIL), which is owned by US-based Pfizer Inc, for Rs 471.60 crore.
"..transaction of the sale of the entire equity stake by the company and its nominees in PAPPL (Pfizer Animal Pharma Pvt Ltd) to PAHIL has been completed and the company has received the consideration amount of Rs 471.60 crore," Pfizer said in a filing to BSE.
Pfizer Ltd had said earlier that the development is part of a global internal re-organisation taken up by its parent, Pfizer Inc, in July 2011 under which it was reviewing strategic alternatives for its global animal health business.
Pfizer's animal health business has presence primarily in the large animal health and poultry market segments and also includes rendering of marketing services.
Pfizer scrip closed at Rs 1,135.35 on the BSE, down 1.43 per cent from its previous close.
- As campaigning picks up, candidates focus on strength areas of rivals
- 143 restaurants offer 30% discount to voters on April 30
- Auto union strike: Drivers demand Tricity permit
- RO serves Pawan Bansal show-cause notice
- BJP releases ‘chargesheet’ listing 16 Cong ‘scams’
- From mobile apps to post cards to call centres, parties go all out to woo voters